Therefore, to avoid potential interference with genetic abnormalities, the J82 bladder cancer cell line was used to establish a stable expression of S1PR1 targeting shRNA clone (Figure 6A–C). This evidence concerns the gene S1PR1 and urinary bladder cancer.